IMCD achieves USD 580M operating EBITA in 2025
The results reflect a complex fiscal period marked by significant macroeconomic headwinds, including geopolitical instability, shifting tariff policies, and adverse foreign exchange movements, which hampered organic growth.
NETHERLANDS – IMCD, a global leader in the distribution and formulation of speciality chemicals and ingredients, reported robust full-year 2025 results with operating EBITA reaching €498 million (USD 579.78 million), reflecting resilience in a volatile market.
The figures highlight steady revenue growth to €4,779 million (USD 5.57 billion) and gross profit of €1,194 million, driven by organic expansion and strategic acquisitions despite foreign-exchange headwinds.
Revenue rose 1% year-over-year to €4,778.9 million (USD 1.39 billion), boosted by +1% organic growth, +4% from new acquisitions, offset by -3% currency impacts.
The company’s diversified portfolio across the pharma, food, coatings, and advanced materials segments maintained a gross profit margin of around 25%, underscoring pricing discipline and value-added services, such as formulation expertise.
Operating EBITA dipped 3% on constant currency due to softer demand in industrial end-markets, but free cash flow climbed 3% to €465 million (USD 541.58 million), enabling shareholder returns and M&A pursuits.
The net result fell 22% to €217.5 million (USD 253.32 million), influenced by higher amortization, finance costs, and one-off organizational tweaks, partially cushioned by lower taxes.
The EMEA region posted revenue of €2,078.1 million (USD 2.42 billion), with gross profit up 2% to €561.3 million (USD 653.78 million), though margins slipped to 27.0% from the acquisition mix.
Americas saw stable 22.5% margins, with gross profit of €282.3 million (USD 328.81 million), while APAC faced organic declines but benefited from acquisition tailwinds.
CEO Marcus Jordan emphasized disciplined execution, noting that 12 acquisitions have added scale in high-growth niches such as sustainable ingredients for clean-label foods.
Marcus Jordan, CEO: “After a good first quarter, the following quarters of 2025 were challenging amid macroeconomic conditions, tariff uncertainty, and geopolitical unrest.” “Despite the market challenges, I’m happy to report that we increased our free cash flow and completed seven strategic acquisitions that complement our offering to customers and suppliers.”
Free cash flow strength supports dividends and bolt-on deals, positioning IMCD for an organic recovery in 2026 amid stabilizing global trade.
With a lean cost structure and €1.2 billion (USD 1.398 billion) gross profit trajectory, IMCD eyes mid-single-digit growth ahead.
This milestone reinforces IMCD’s stature as a formulation partner driving innovation in edible applications worldwide.
Looking ahead to 2026, IMCD remains focused on operational excellence and digital transformation.
The company has begun implementing a proprietary AI-driven sales recommendation tool to improve cross-selling ratios.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
